Ameya S. Champhekar - Concepedia

Author

Ameya S. Champhekar

University of California, Los Angeles ORCID

Also Known As

A. Champhekar, Ameya Champhekar, Ameya S. Champhekar

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Parker Institute for Cancer Immunotherapy UCLA Jonsson Comprehensive Cancer Center California Institute of Technology University of Lausanne

About

Ameya S. Champhekar is an author at University of California, Los Angeles specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.1K
2	Cell Biology	6	6	848
3	Health Sciences	1	1	256
4	Cellular Physiology	1	1	278
5	Endocrinology	1	1	256

Ameya S. Champhekar

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko, Cancer Cell Tumor ImmunologyCancer ImmunosurveillanceMelanomaImmunologyTumor Immunity	2020	361
Positive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation Hao Yuan Kueh, Ameya S. Champhekar, Stephen L. Nutt, Science Positive FeedbackCell CycleGene Regulatory NetworkCellular PhysiologyMyeloid Neoplasia	2013	278
Differential control of peripheral circadian rhythms by suprachiasmatic-dependent neural signals Hongnian Guo, Judy McKinley Brewer, Ameya S. Champhekar, Proceedings of the National Academy of Sciences Central PacemakerHomeostatic MechanismNeurotransmissionClock Gene ExpressionNeural Mechanism	2005	256
Notch1 and TGFβ1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells Jeremy B. Samon, Ameya S. Champhekar, Lisa M. Minter, Blood	2008	188
Overcoming Genetically Based Resistance Mechanisms to PD-1 Blockade Davis Y. Torrejon, Gabriel Abril-Rodríguez, Ameya S. Champhekar, Cancer Discovery	2020	137
GATA-3 Dose-Dependent Checkpoints in Early T Cell Commitment Deirdre D. Scripture-Adams, Sagar Damle, Li Long, The Journal of Immunology	2014	81
Regulation of early T-lineage gene expression and developmental progression by the progenitor cell transcription factor PU.1 Ameya S. Champhekar, Sagar Damle, George Freedman, Genes & Development Lymphocyte DevelopmentGeneticsT-regulatory CellDevelopmental ProgressionModified Antagonist Pu.1	2015	71
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence Cameron R. Cunningham, Ameya S. Champhekar, Michael V. Tullius, PLoS Pathogens Immune ActivationAdaptive Immune SystemImmunologyViral PathogenesisImmunodominance	2016	69
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti–PD-1 therapy Yeon Joo Kim, Katherine M. Sheu, Jennifer Tsoi, Journal of Clinical Investigation	2021	67
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko, Cancer Cell Tumor ImmunologyCancer ImmunosurveillanceMelanomaImmunologyTumor Immunity	2020	51

Page 1